文献库搜索 | GeneLibs

Margalit(O),Stemmer(A),Chapin(WJ),Shacham-... Clin Colorectal Cancer 2026-07-31

...mOS) was 14.4 months - not reached for those who achieved CR/PR and 1.7 months for those whose best response was PD. For...

Vetere(G),Osterlund(E),Yousef(MMG),Payapwa... J Immunother Cancer 2026-09-02

...mOS) was 10.8 months with ICIs and 9.0 months with SOC (HR 0.76, 95% CI 0.64 to 0.92, p=0.004). In patients without live...

Liu(L),Lu(D),Xu(C),Geng(L),Lai(CJ),Yan(X) Biomed Microdevices 2026-09-05

...MoS₂/NiO nanocomposite was constructed for the quantitative determination of ten estrogenic compounds. To complement the...

Cheung(MW),Choi(JD),Stempak(JM),Chandran(V... J Immunol 2026-07-10

...mos following the second vaccine dose in IMID patients compared to healthy controls, raising the possibility that a subo...

An(N),Wang(G),Wang(M) Dev Comp Immunol 2026-08-00

...mos-like (LvSTK) is a bacterial-derived horizontally transferred gene (HTG) identified in the L. vannamei genome. In the...

Altaib(H),Suzuki(T),Morioka(T),Abe(M),Badr(Y) Front Biosci (Elite Ed) 2026-06-05

...MOS), on fecal GABA concentrations using the Kobe University Human Intestinal Microbiota Model (KUHIMM), an in vitro sim...

Zhao(X),Yang(M),Zhang(J),Kong(Y),Xu(M),Che... Immunother Adv 2026-00-00

...mOS) was 11.1 months (95% CI: 5.3-16.9 months). The Geriatric Nutritional Risk Index (GNRI) was associated with the effi...

Tada(H),Naya(SI) Chem Sci 2026-08-17

...MOs) exhibit extremely high catalytic activity for CO oxidation even at 203 K has led to the current remarkable developm...

Lee(JD),Kim(HY),Lee(JY),Sung(CR),Kwack(SJ)... Toxicol Res 2026-09-00

...most relevant endpoint for systemic exposure. Human exposure was estimated using the cosmetic exposure assessment approa...

Zhang(A),Ma(Y),Liu(Y),Dong(S),Torres(MN),K... Small Methods 2026-02-00

...MOS)-modified chondroitin sulfate and hyaluronic. This hydrogel forms a porous structure in situ, supporting cell adhesi...